RepliCel Life Sciences Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was CAD 0.311734 million compared to CAD 0.743228.
RepliCel Announces Secured Loan Agreement VANCOUVER, BC, CANADA -April 17, 2024 - RepliCel Life Sciences Inc. , a company developing next-generation technologies in.